BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1487625)

  • 1. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients.
    McAdams C; Leonard BE
    Int Clin Psychopharmacol; 1992 Nov; 7(2):81-5. PubMed ID: 1487625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Status-dependent neurochemical parameters in schizophrenic and affective diseases].
    Gross G; Huber G; Klosterkötter J; Rao ML; Linz M
    Fortschr Neurol Psychiatr; 1990 Apr; 58(4):154-60. PubMed ID: 1972372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression.
    Gómez-Gil E; Gastó C; Díaz-Ricart M; Carretero M; Salamero M; Catalán R; Escolar G
    Hum Psychopharmacol; 2002 Dec; 17(8):419-24. PubMed ID: 12457378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Affective, schizoaffective and schizophrenic psychoses. A comparative long-term study].
    Marneros A; Deister A; Rohde A
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 65():1-454. PubMed ID: 1791861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
    Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intolerance of ambiguity in affective and schizophrenic disorders].
    Heerlein A; Richter P
    Nervenarzt; 1991 May; 62(5):269-73. PubMed ID: 1865955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of daylight exposure on platelet 5-HT levels in patients with major depression and schizophrenia.
    Ljubicić D; Stipcević T; Pivac N; Jakovljević M; Mück-Seler D
    J Photochem Photobiol B; 2007 Dec; 89(2-3):63-9. PubMed ID: 17937992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R; Russo M; Raimondo V
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):569-75. PubMed ID: 7378191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-hydroxytryptamine and platelet aggregation.
    De Clerck FF; Herman AG
    Fed Proc; 1983 Feb; 42(2):228-32. PubMed ID: 6822293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women.
    Muck-Seler D; Pivac N; Mustapic M; Crncevic Z; Jakovljevic M; Sagud M
    Psychiatry Res; 2004 Jul; 127(3):217-26. PubMed ID: 15296821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of attribution of intentions to others in schizophrenia using an ecological video-based task: a comparison with manic and depressed patients.
    Bazin N; Brunet-Gouet E; Bourdet C; Kayser N; Falissard B; Hardy-Baylé MC; Passerieux C
    Psychiatry Res; 2009 May; 167(1-2):28-35. PubMed ID: 19346006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation response in schizophrenia and prostaglandin E1.
    Kaiya H; Imai H; Muramatsu Y; Nozaki M; Fujimura H; Adachi S; Namba M
    Psychiatry Res; 1983 Aug; 9(4):309-18. PubMed ID: 6139836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet serotonin levels in schizophrenia: relationship to race and psychopathology.
    Jackman H; Luchins D; Meltzer HY
    Biol Psychiatry; 1983 Aug; 18(8):887-902. PubMed ID: 6615945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of maternal and neonatal platelet function.
    Barradas MA; Mikhailidis DP; Imoedemhe DA; Djahanbakhch O; Craft IL; Dandona P
    Biol Res Pregnancy Perinatol; 1986; 7(2):60-5. PubMed ID: 3730472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sympathomimetic amines with collagen, calcium ionophor and adenosine diphosphate in their effects on thromboxane formation of human platelet rich plasma.
    Ditter H; Matthias FR; Lasch HG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):761-8. PubMed ID: 6083951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gallopamil and changes of adenosine diphosphate- and collagen-induced thrombocyte aggregation].
    Költringer P; Langsteger W; Lind P; Pierer G; Reisecker F; Eber O
    Arzneimittelforschung; 1991 Aug; 41(8):786-8. PubMed ID: 1781797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.